Clinical Trial Update: Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating the safety and preliminary efficacy of an oral taxane in combination with pemetrexed (Alimta) in patients with recurrent non-small ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Oral taxane

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED